US 7220853
Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1
granted A61KA61K38/00A61K48/00
Quick answer
US patent 7220853 (Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1) held by The Board of Regents of the University of Texas System expires Mon May 17 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue May 22 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 17 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K38/00, A61K48/00, A61P, A61P35/00